Doo Hwan Oh

Title: Doo Hwan Oh: Innovator in Glaucoma Treatment

Introduction

Doo Hwan Oh is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach has the potential to improve the quality of life for many individuals suffering from this condition.

Latest Patents

Doo Hwan Oh holds a patent for a pharmaceutical composition aimed at the prevention or treatment of glaucoma. The patent, titled "Angiogenin for treatment of glaucoma," describes a composition that includes angiogenin or a fragment thereof as an active ingredient. This invention works by activating aqueous humor outflow, which leads to an increase in nitric oxide generation, expansion of Schlemm's canal, and widening of intercellular intervals. As a result, it effectively reduces intraocular pressure, making it a promising option for glaucoma treatment.

Career Highlights

Doo Hwan Oh is affiliated with Chung Ang University Industry Academic Cooperation, where he continues to engage in research and development. His work is characterized by a commitment to advancing medical science and improving therapeutic options for patients.

Collaborations

Some of his notable coworkers include Kwang Sic Joo and Yeoun Sook Chun, who contribute to the collaborative efforts in research and innovation within the institution.

Conclusion

Doo Hwan Oh's contributions to glaucoma treatment through his innovative patent highlight the importance of research in medical advancements. His work exemplifies the potential of scientific inquiry to address pressing health issues.